These findings suggest a potential role for CAF-C7 in modulating tumor cell responses through IGF-I; however, we acknowledge that these effects may differ in primary epithelial tumor cells owing to the intrinsic heterogeneity of ovarian cancers. This evidence concerns the gene IGF1 and ovarian carcinoma.